Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

No data is available on the toxicokinetics, metabolism and distribution of nonylphenol ethoxylate, sarcosine derivative (CAS no 75627-31-5). Based on the toxicological profile of the substance this information is not considered as a requirement. The information in this chapter has therefore been derived based on the physicochemical properties of the substance, information from QSAR models, i.e. QSAR Toolbox (v.3.1) and EpiSuite (v. 4.1) and information on bioaccumulation potential from the chapter on environmental fate and pathways.

Key value for chemical safety assessment

Bioaccumulation potential:
low bioaccumulation potential

Additional information

No data is available on the toxicokinetics, metabolism and distribution of nonylphenol ethoxylate, sarcosine derivative (CAS no 75627-31-5). Based on the toxicological profile of the substance this information is not considered as a requirement. The information in this chapter has therefore been derived based on the physicochemical properties of the substance, information from QSAR models, i.e. QSAR Toolbox (v.3.1) and EpiSuite (v. 4.1) and information on bioaccumulation potential from the chapter on environmental fate and pathways.

Nonylphenol ethoxylate, sarcosine derivative (CAS no 75627-31-5)has a molecular weight of 431.5 g/Mol, a log Kow of 3.9 and pKa value of 1.44 for the carbon and 9.39 for the nitrogen. It is a slightly water soluble solution with a vapour pressure of 0.87 Pa at 20°C.

The potential absorption via oral route is considered to be complete, although this is not a likely route of exposure. Based on the results from the EpiSuite v4.1 estimation of the absorption of the substance via dermal route is considered to be low. As a worst case, absorption via the inhalational route is also considered to be complete, although exposure to the substance via inhalation is unlikely based on the handling of the substance at dedicated facilities. The substance is not considered to have a potential for bioaccumulation, based on the Log Kow of 3.9, which is below the criterion of log Kow < 4.5.